Joseph Chou
Joseph Chou

We are really pleased to announce that we have officially created a representative office in Taïwan (company 仿生培養技術中心 ID number 90729614) which is directed by our partner, Joseph Chou 周肇隆 ジョーゼフ・チョウ, member of our advisory board.

Thanks to Joseph and Professor Szecheng J. Lo, member of our scientific advisory board, all four major government endorsed biotech research and development institutions in Taiwan (Academia Sinica, Industrial Technology Research Institute (ITRI), Development Center for Biotechnology (DCB) and National Health Research Institutes (NHRI)) partnered with HCS Pharma to begin BIOMIMESYS® trial implementations in their laboratories.

For example, we are working in partnership with DCB to help researchers to differentiate induced pluripotent stem cells into neuronal cells in 3D by using BIOMIMESYS®. We are also working with researchers in oncology field by using BIOMIMESYS® oncology and in liver disease such as hepatitis infection by using BIOMIMESYS® liver.

In order to enhance partnerships in Taïwan, we have been accepted to be an incubate company in the technology transfer and incubation center of the National Health Research Institute (NHRI). In partnership with researchers in Europe and in Taïwan, we will combine the state of the art technologies: BIOMIMESYS® for in vitro organ-specific ECM, semiconductors for real-time analysis and microfluidic devices for dynamic implementation to develop the first 3D organ-specific biochip systems allowing to analyze cells in real time. In addition to continue the development of BIOMIMESYS® in drug discovery, we will also work in close partnership with researchers from NHRI on the use of BIOMIMESYS®in cell therapy. In the near future, we will be able to implement a new technical center in Taïwan.

We really want to thank you our partners in Taïwan, Joseph Chou and Prof Szecheng J. Lo, for their invaluable support

Image by Kim Nguyen from Pixabay.


Join us today at BIO-Asia Taiwan online exhibition! - HCS Pharma · July 19, 2021 at 2:04 pm

[…] attend this event as a member of the incubation center of the NHRI (National Health Research Institute) and we want to thank NHRI representative and […]

Meet us at the Investment Forum of European Technology Chamber - HCS Pharma · August 24, 2021 at 3:13 pm

[…] we are in development both in Asia, in USA and in Europe we are looking for investors to grow faster and to accelerate the development […]

Visit us at BIO Asia-Taiwan from 4 to 7 November (Taipei) - HCS Pharma · November 2, 2021 at 11:45 am

[…] are very happy to be present at BIO Asia-Taiwan this week as a member of the National Health Research Institutes (NHRI) Technology Transfer & Incubation Center (TTIC). You can find us on the NHRI’s […]

BIOMIMESYS®, le futur de la recherche de médicament est "Made in France" - HCS Pharma · November 12, 2021 at 3:20 pm

[…] nous sommes toutefois obligé de constater que nos soutiens se trouvent plutôt outre Atlantique ou en Asie qu’au niveau national ou régional. Nous espérons que les discours sur l’importance de […]

HCS Pharma awarded by an Innovation Award from NHRI during BioAsia in Taïwan - HCS Pharma · November 18, 2021 at 2:06 pm

[…] were very happy to be present at BIO Asia-Taiwan from 4 to 7 November as a member of the National Health Research Institutes (NHRI) Technology Transfer & Incubation Center (TTIC). Joseph CHOU, the representative of HCS Pharma Taïwan, and his team have presented our products […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.